LINTHICUM, Md., Oct. 12, 2005 (PRIMEZONE) -- Dialysis Corporation of America (Nasdaq:DCAI) announced the completion of a nine station mobile dialysis facility, initially being operated in South Carolina.
This new facility is completely movable from one location to another and has been designed to meet the requirements of each of the states in which the company is currently operating.
President & CEO Stephen Everett commented, "The development of this exciting new facility provides DCA with a unique opportunity to begin serving the communities that we are planning on building permanent centers in earlier than would otherwise be possible. There are obvious competitive, clinical, and financial advantages associated with this center, and we plan on relocating the facility to areas where it will bring the most value to patients and the company."
The 3,360-square-foot facility will be able to care for more than 50 patients, is fully equipped with state-of-the-art dialysis machines and water treatment systems, and can be transferred to a new location in less than 90 days. The center recently passed state inspection in South Carolina and is already serving dozens of new patients in Aiken, while a second permanent facility is being constructed in the area.
Dialysis Corporation of America owns and operates freestanding kidney hemodialysis centers located in Georgia, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina, and Virginia, and provides in-hospital dialysis services on a contract basis to certain hospitals located in the those states. The company provides patients with their choice of a full range of quality in-center, acute or at-home hemodialysis services.
This release contains forward-looking statements that are subject to risks and uncertainties that could affect the business and prospects of the company and cause actual results and plans to differ materially from those anticipated. Those factors include, but are not limited to, certain delays beyond the company's control with respect to future business events, the highly competitive environment in the establishment and operation of dialysis centers, the ability to develop or acquire additional dialysis facilities, whether patient bases of the company's facilities can expand to provide profitability, regulation of dialysis operations, government rate determination for Medicare reimbursement, and other risks detailed in the company's filings with the Securities and Exchange Commission, particularly as described in the company's proxy statement/prospectus dated August 12, 2005 and in its annual report on Form 10-K/A1 for the fiscal year ended December 31, 2004.
Other Dialysis Corporation of America press releases, corporate profile, corporate governance materials, quarterly and current reports, and other filings with the Securities and Exchange Commission are available on Dialysis Corporation of Americas Internet home page http://www.dialysiscorporation.com.